These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 38075698)

  • 1. Unlocking the potential of RNA-based therapeutics in the lung: current status and future directions.
    Man HSJ; Moosa VA; Singh A; Wu L; Granton JT; Juvet SC; Hoang CD; de Perrot M
    Front Genet; 2023; 14():1281538. PubMed ID: 38075698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism.
    Amanpour S
    Arch Razi Inst; 2021 Mar; 76(1):1-6. PubMed ID: 33818952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-liver mRNA Delivery.
    Loughrey D; Dahlman JE
    Acc Chem Res; 2022 Jan; 55(1):13-23. PubMed ID: 34859663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complex Coacervates as a Promising Vehicle for mRNA Delivery: A Comprehensive Review of Recent Advances and Challenges.
    Forenzo C; Larsen J
    Mol Pharm; 2023 Sep; 20(9):4387-4403. PubMed ID: 37561647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in the delivery of RNA therapeutics: from concept to clinical reality.
    Kaczmarek JC; Kowalski PS; Anderson DG
    Genome Med; 2017 Jun; 9(1):60. PubMed ID: 28655327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA therapeutics: Molecular mechanisms, and potential clinical translations.
    Nguyen TT; Nguyen Thi YV; Chu DT
    Prog Mol Biol Transl Sci; 2024; 203():65-82. PubMed ID: 38360006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current Status and Future Perspectives on MRNA Drug Manufacturing.
    Webb C; Ip S; Bathula NV; Popova P; Soriano SKV; Ly HH; Eryilmaz B; Nguyen Huu VA; Broadhead R; Rabel M; Villamagna I; Abraham S; Raeesi V; Thomas A; Clarke S; Ramsay EC; Perrie Y; Blakney AK
    Mol Pharm; 2022 Apr; 19(4):1047-1058. PubMed ID: 35238565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. mRNA vaccines for COVID-19 and diverse diseases.
    Hussain A; Yang H; Zhang M; Liu Q; Alotaibi G; Irfan M; He H; Chang J; Liang XJ; Weng Y; Huang Y
    J Control Release; 2022 May; 345():314-333. PubMed ID: 35331783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developing Biodegradable Lipid Nanoparticles for Intracellular mRNA Delivery and Genome Editing.
    Qiu M; Li Y; Bloomer H; Xu Q
    Acc Chem Res; 2021 Nov; 54(21):4001-4011. PubMed ID: 34668716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nucleic acid delivery and nanoparticle design for COVID vaccines.
    Andresen JL; Fenton OS
    MRS Bull; 2021; 46(9):832-839. PubMed ID: 34539057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNA in Cancer Immunotherapy: Unlocking the Potential of the Immune System.
    De Mey W; Esprit A; Thielemans K; Breckpot K; Franceschini L
    Clin Cancer Res; 2022 Sep; 28(18):3929-3939. PubMed ID: 35583609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccines' New Era-RNA Vaccine.
    Zhou W; Jiang L; Liao S; Wu F; Yang G; Hou L; Liu L; Pan X; Jia W; Zhang Y
    Viruses; 2023 Aug; 15(8):. PubMed ID: 37632102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid nanoparticles for delivery of RNA therapeutics: Current status and the role of
    Jung HN; Lee SY; Lee S; Youn H; Im HJ
    Theranostics; 2022; 12(17):7509-7531. PubMed ID: 36438494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanoparticle Delivery Platforms for RNAi Therapeutics Targeting COVID-19 Disease in the Respiratory Tract.
    Zhang Y; Almazi JG; Ong HX; Johansen MD; Ledger S; Traini D; Hansbro PM; Kelleher AD; Ahlenstiel CL
    Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Innovative developments and emerging technologies in RNA therapeutics.
    Halloy F; Biscans A; Bujold KE; Debacker A; Hill AC; Lacroix A; Luige O; Strömberg R; Sundstrom L; Vogel J; Ghidini A
    RNA Biol; 2022; 19(1):313-332. PubMed ID: 35188077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthetic modified messenger RNA for therapeutic applications.
    Gao M; Zhang Q; Feng XH; Liu J
    Acta Biomater; 2021 Sep; 131():1-15. PubMed ID: 34133982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Development of mRNA Vaccines: Challenges and Opportunities.
    August A; Brito L; Paris R; Zaks T
    Curr Top Microbiol Immunol; 2022; 440():167-186. PubMed ID: 35906319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary drug delivery: an effective and convenient delivery route to combat COVID-19.
    Alipour S; Mahmoudi L; Ahmadi F
    Drug Deliv Transl Res; 2023 Mar; 13(3):705-715. PubMed ID: 36260223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assembling the RNA therapeutics toolbox.
    Teng M; Xia ZJ; Lo N; Daud K; He HH
    Med Rev (2021); 2024 Apr; 4(2):110-128. PubMed ID: 38680684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formulation, Device, and Clinical Factors Influencing the Targeted Delivery of COVID-19 Vaccines to the Lungs.
    Mossadeq S; Shah R; Shah V; Bagul M
    AAPS PharmSciTech; 2022 Nov; 24(1):2. PubMed ID: 36416999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.